USP18 lack in microglia causes destructive interferonopathy of the mouse brain

Tobias Goldmann1, Nicolas Zeller1, Jenni Raasch1

  • 1Institute of Neuropathology, University of Freiburg, Freiburg, Germany.

The EMBO Journal
|April 22, 2015
PubMed

Insights

Ubiquitin-specific protease (Usp) 18 maintains quiescent microglia by regulating Stat1 and interferon signaling. This discovery reveals Usp18 as a key molecule preventing microgliopathies and protecting microglial function.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Microglia, the resident immune cells of the central nervous system (CNS), are crucial for maintaining tissue homeostasis.
  • Dysregulation of microglia is implicated in various neurological disorders, termed microgliopathies.
  • The intracellular mechanisms controlling microglial activation remain incompletely understood.

Purpose of the Study:

  • To investigate the role of ubiquitin-specific protease (Usp) 18 in regulating microglial function.
  • To elucidate the molecular mechanisms by which Usp18 controls microglial activation and interferon signaling.

Main Methods:

  • Identification of Usp18 in white matter microglia.
  • Analysis of Usp18's effect on Stat1 activation and interferon-induced gene expression.
  • Investigation of Usp18's interaction with Ifnar2 and the functional consequences of Ifnar1 absence.

Main Results:

  • Usp18 was identified as a key contributor to microglial quiescence.
  • Microglial Usp18 negatively regulates Stat1 activation and interferon signaling by interacting with Ifnar2.
  • Absence of Ifnar1 restored microglial activation, suggesting a tonic interferon signal regulated by Usp18.

Conclusions:

  • Usp18 acts as a critical negative regulator of microglia activation.
  • Usp18 plays a protective role in microglial function by modulating the interferon (IFN) pathway.
  • Usp18 is identified as a novel therapeutic target for preventing destructive microgliopathies.

Related Concept Videos